Differential modulation of emotion processing brain regions by noradrenergic and serotonergic antidepressants

RationaleMost widely used antidepressant drugs affect the serotonergic and noradrenergic pathways. However, there are currently no neurobiological criteria for selecting between these targets and predicting the treatment response in individual depressed patients.ObjectivesThe current study is aimed at differentiating brain regions known to be pathophysiologically and functionally involved in depression-related emotion processing with respect to their susceptibility to serotonergic and noradrenergic modulation.MethodsIn a single-blind pseudo-randomized crossover study, 16 healthy subjects (out of 21 enrolled) were included in analysis after ingesting a single dose of citalopram (a selective serotonin-reuptake inhibitor, 40 mg), reboxetine (a selective noradrenaline-reuptake inhibitor, 8 mg), or placebo at three time points prior to functional magnetic resonance imaging (fMRI). During fMRI, subjects anticipated and subsequently viewed emotional pictures. Effects of serotonergic and noradrenergic modulation versus placebo on brain activity during the perception of negative pictures were analyzed with a repeated measures ANOVA in the whole brain and in specific regions of interest relevant to depression.ResultsNoradrenergic modulation by reboxetine increased brain activity in the thalamus, right dorsolateral prefrontal cortex and occipital regions during the perception of negative emotional stimuli. Citalopram primarily affected the ventrolateral prefrontal cortical regions.ConclusionThe brain regions involved in the processing of negative emotional stimuli were differentially modulated by selective noradrenergic and serotonergic drugs: thalamic activity was increased by reboxetine, whereas citalopram primarily affected ventrolateral prefrontal regions. Thus, dysfunction in these regions, which could be identified in depressed patients, may predict treatment responses to either noradrenergic or serotonergic antidepressants.

[1]  Marc Laruelle,et al.  Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites , 1988, Biological Psychiatry.

[2]  A. Simmons,et al.  Escitalopram effects on insula and amygdala BOLD activation during emotional processing , 2008, Psychopharmacology.

[3]  Catherine J. Harmer,et al.  Effect of a single dose of citalopram on amygdala response to emotional faces , 2009, British Journal of Psychiatry.

[4]  S. Rauch,et al.  Neurobiology of emotion perception II: implications for major psychiatric disorders , 2003, Biological Psychiatry.

[5]  J. Jolles,et al.  The effect of acute tryptophan depletion on the BOLD response during performance monitoring and response inhibition in healthy male volunteers , 2006, Psychopharmacology.

[6]  H. Mayberg.  Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. , 2003, British medical bulletin.

[7]  C. Halldin,et al.  Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain , 2004, Human brain mapping.

[8]  Henrik Walter,et al.  Noradrenergic enhancement of amygdala responses to fear. , 2009, Social cognitive and affective neuroscience.

[9]  Martin Wiesmann,et al.  Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. , 2011, The Journal of clinical psychiatry.

[10]  Andrew Simmons,et al.  Neural abnormalities during cognitive generation of affect in Treatment-Resistant depression , 2003, Biological Psychiatry.

[11]  M. Phillips,et al.  Effects of acute tryptophan depletion on neural processing of facial expressions of emotion in humans , 2010, Psychopharmacology.

[12]  T. Baumgartner,et al.  Neural correlates of ‘pessimistic’ attitude in depression , 2009, Psychological Medicine.

[13]  Heinrich Sauer,et al.  Differential effects of serotonergic and noradrenergic antidepressants on brain activity during a cognitive control task and neurofunctional prediction of treatment outcome in patients with depression. , 2010, Journal of psychiatry & neuroscience : JPN.

[14]  D. Perrett,et al.  Acute SSRI Administration Affects the Processing of Social Cues in Healthy Volunteers , 2003, Neuropsychopharmacology.

[15]  Patrick M Fisher,et al.  Acute 5-HT Reuptake Blockade Potentiates Human Amygdala Reactivity , 2008, Neuropsychopharmacology.

[16]  J. Fleishaker,et al.  Clinical Pharmacokinetics of Reboxetine, a Selective Norepinephrine Reuptake Inhibitor for the Treatment of Patients with Depression , 2000, Clinical pharmacokinetics.

[17]  Rebecca Elliott,et al.  Citalopram modulation of neuronal responses to aversive face emotions: a functional MRI study , 2007, Neuroreport.

[18]  S Surguladze,et al.  Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score , 2009, Journal of psychopharmacology.

[19]  John Suckling,et al.  Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. , 2004, Archives of general psychiatry.

[20]  G. Fink,et al.  Noradrenergic modulation of cortical networks engaged in visuomotor processing. , 2010, Cerebral cortex.

[21]  J. Hyttel,et al.  Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity , 1982, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  C. Halldin,et al.  Post-mortem human brain autoradiography of the norepinephrine transporter using (S,S)-[18F]FMeNER-D2 , 2005, European Neuropsychopharmacology.

[23]  C. Martin-Soelch,et al.  Modelle der Substanzabhängigkeit Neurobiologische und neuropsychologische Modelle der Substanzabhängigkeit , 2010 .

[24]  T. Bschor.  Therapy-resistant depression , 2010, Expert review of neurotherapeutics.

[25]  P. Cowen,et al.  The effects of reboxetine on emotional processing in healthy volunteers: an fMRI study , 2008, Molecular Psychiatry.

[26]  R. Post,et al.  Bupropion and venlafaxine responders differ in pretreatment regional cerebral metabolism in unipolar depression , 2005, Biological Psychiatry.

[27]  Michael J. Anderle,et al.  The neural substrates of affective processing in depressed patients treated with venlafaxine. , 2003, The American journal of psychiatry.

[28]  T. Robbins,et al.  Serotoninergic regulation of emotional and behavioural control processes , 2008, Trends in Cognitive Sciences.

[29]  P. Cowen,et al.  Increased Positive versus Negative Affective Perception and Memory in Healthy Volunteers following Selective Serotonin and Norepinephrine Reuptake Inhibition , 2022 .

[30]  Sylvain Houle,et al.  Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study. , 2004, The American journal of psychiatry.

[31]  C Dockery,et al.  The effect of tryptophan depletion on brain activation measured by functional magnetic resonance imaging during the Stroop test in healthy subjects. , 2005, Physiological research.

[32]  M. Mintun,et al.  Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study , 2001, Biological Psychiatry.

[33]  M. Popoli,et al.  Time-dependent biphasic modulation of human BDNF by antidepressants in neuroblastoma cells , 2008, BMC Neuroscience.

[34]  Uwe Herwig,et al.  Serotonergic and Noradrenergic Modulation of Emotion Processing by Single Dose Antidepressants , 2010, Neuropsychopharmacology.

[35]  J. Geddes,et al.  Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis , 2009, The Lancet.

[36]  F. Henn,et al.  New insights into the mechanisms of antidepressant therapy. , 2004, Pharmacology & therapeutics.

[37]  Guy M. Goodwin,et al.  Single dose antidepressant administration modulates the neural processing of self-referent personality trait words , 2007, NeuroImage.

[38]  Gereon R. Fink,et al.  Modeling a Negative Response Bias in the Human Amygdala by Noradrenergic–Glucocorticoid Interactions , 2008, The Journal of Neuroscience.

[39]  R. Dolan,et al.  The neural basis of mood-congruent processing biases in depression. , 2002, Archives of general psychiatry.

[40]  Alan Frazer,et al.  Onset and Early Behavioral Effects of Pharmacologically Different Antidepressants and Placebo in Depression , 2004, Neuropsychopharmacology.

[41]  K. Phan,et al.  Evidence for modulation of facial emotional processing bias during emotional expression decoding by serotonergic and noradrenergic antidepressants: an event-related potential (ERP) study , 2009, Psychopharmacology.

[42]  S. Sara.  The locus coeruleus and noradrenergic modulation of cognition , 2009, Nature Reviews Neuroscience.

[43]  P. Buckley,et al.  Electroencephalographic Alpha Measures Predict Therapeutic Response to a Selective Serotonin Reuptake Inhibitor Antidepressant: Pre- and Post-Treatment Findings , 2009 .

[44]  R. Elliott,et al.  Neuronal effects of acute citalopram detected by pharmacoMRI , 2005, Psychopharmacology.

[45]  Angela R Laird,et al.  A meta‐analytic study of changes in brain activation in depression , 2008, Human brain mapping.

[46]  E. Formisano,et al.  Sustained attention and serotonin: a pharmaco‐fMRI study , 2008, Human psychopharmacology.

[47]  Philip K. McGuire,et al.  Modulation of neural response to happy and sad faces by acute tryptophan depletion , 2007, Psychopharmacology.

[48]  R. Blakely,et al.  Pharmacological profile of antidepressants and related compounds at human monoamine transporters. , 1997, European journal of pharmacology.

[49]  Cynthia H. Y. Fu,et al.  Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI , 2005, Psychopharmacology.

[50]  Lutz Jäncke,et al.  Neural correlates of a ‘pessimistic’ attitude when anticipating events of unknown emotional valence , 2007, NeuroImage.

[51]  A. Laird,et al.  A meta‐analytic study of changes in brain activation in depression , 2008 .